From: Comprehensive molecular characteristics of hepatocellular carcinoma based on multi-omics analysis
Metabolite | Trend | Mode | VIP | FC | Log2FC | Adjusted p-value |
---|---|---|---|---|---|---|
PI (6 keto-PGF1alpha/16:0) | up | ESI- | 2.4039 | 1.3273 | 0.4085 | 1.514E-07 |
N-Amidino-L-aspartate | down | ESI+ | 2.9828 | 0.6812 | -0.5538 | 3.926E-07 |
Lupex | down | ESI- | 2.9952 | 0.6492 | -0.6233 | 6.446E-07 |
13,16,19-Docosatrienoic acid | up | ESI- | 2.3091 | 1.2007 | 0.2639 | 0.000001507 |
2,3,4,5-Tetrahydro-2-pyridinecarboxylic acid | down | ESI- | 3.1523 | 0.6443 | -0.6342 | 0.000002089 |
PA (18:2(9Z,12Z)/20:1(11Z)) | up | ESI- | 1.4519 | 1.0623 | 0.0872 | 0.000003408 |
(2E)-Non-2-enedioylcarnitine | down | ESI- | 2.7138 | 0.6521 | -0.6168 | 0.000006465 |
Azaserine | down | ESI+ | 2.5226 | 0.7374 | -0.4395 | 0.000007775 |
Tetracosapentenoic acid | up | ESI- | 2.2002 | 1.1919 | 0.2533 | 0.000009136 |
Stearoyllactic acid | up | ESI- | 1.5042 | 1.0968 | 0.1333 | 0.00000983 |
5,8,11-Eicosatrienoic acid | up | ESI- | 1.9709 | 1.199 | 0.2618 | 0.00001021 |
Abacavir | down | ESI- | 2.8114 | 0.6381 | -0.6481 | 0.00001227 |
Cytidine-5’-diphosphocholine | up | ESI- | 2.6111 | 1.3479 | 0.4307 | 0.00001821 |
(6R)-Folinic acid | down | ESI- | 2.9997 | 0.6269 | -0.6737 | 0.00002248 |
Citric Acid | up | ESI- | 1.1145 | 1.0479 | 0.0675 | 0.00002444 |
PG (18:2(9Z,12Z)/18:1(9Z)) | up | ESI- | 1.7352 | 1.0973 | 0.134 | 0.00002644 |
PG (20:3(6,8,11)-OH(5)/18:2(9Z,12Z)) | up | ESI- | 1.8584 | 1.136 | 0.184 | 0.00003883 |
6-Lactoyltetrahydropterin | down | ESI- | 2.2779 | 0.7165 | -0.481 | 0.00004214 |
Pirbuterol | down | ESI- | 2.877 | 0.5816 | -0.7819 | 0.00004833 |
L-Hexanoylcarnitine | down | ESI+ | 2.2113 | 0.8171 | -0.2914 | 0.00005157 |